Dr Reddy's plans clinical trials of Sputnik Light for children, use as booster dose

Dr Reddy's plans clinical trials of Sputnik Light for children, use as booster dose The drug maker said it is in the midst of finalising the protocol to begin the trials on children and adolescents which will have two cohorts one for 12-18 years and 2-12 years age groups. "The dosing requirement is likely to be different for two cohorts," said Deepak Sapra, CEO of API & Services, Dr Reddy's, to media. https://ift.tt/eA8V8J